Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease (COVID-19), spreading from Wuhan to worldwide has been emerged since December 2019. Although scientists and researchers have been racing to develop specific therapeutic agents or vaccines against SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yılmaz, Soner, Ertuğrul Örüç, Nigar, Özcebe, Osman İlhami, Azap, Alpay, Çetin, Ahmet Türker, Yenicesu, İdil, Öztürk, Abdullah, Gündüz, Mehmet, Tekin, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271837/
https://www.ncbi.nlm.nih.gov/pubmed/32593519
http://dx.doi.org/10.1016/j.transci.2020.102846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271837/
https://www.ncbi.nlm.nih.gov/pubmed/32593519
http://dx.doi.org/10.1016/j.transci.2020.102846

Ejemplares similares